R C Stern

474 total citations
12 papers, 381 citations indexed

About

R C Stern is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, R C Stern has authored 12 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 2 papers in Surgery and 2 papers in Molecular Biology. Recurrent topics in R C Stern's work include Cystic Fibrosis Research Advances (8 papers), Pancreatic function and diabetes (2 papers) and Liver Disease and Transplantation (1 paper). R C Stern is often cited by papers focused on Cystic Fibrosis Research Advances (8 papers), Pancreatic function and diabetes (2 papers) and Liver Disease and Transplantation (1 paper). R C Stern collaborates with scholars based in United States. R C Stern's co-authors include Rochelle Hirschhorn, Catherine Demko, Mary Jane Thomassen, Bernard Boxerbaum, Stephen C. Aronoff, LeRoy W. Matthews, Steven M. Stowe, Austin Tucker, Thomas F. Boat and Girish Sharma and has published in prestigious journals such as The Lancet, JAMA and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

R C Stern

12 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R C Stern United States 8 213 151 86 67 44 12 381
J. Riethmueller Germany 12 377 1.8× 173 1.1× 139 1.6× 66 1.0× 16 0.4× 17 609
Giovanna Pizzamiglio Italy 8 135 0.6× 87 0.6× 59 0.7× 45 0.7× 11 0.3× 16 270
Hannah Bayes United Kingdom 10 92 0.4× 246 1.6× 125 1.5× 37 0.6× 22 0.5× 18 487
I Rayet France 8 79 0.4× 91 0.6× 37 0.4× 25 0.4× 84 1.9× 28 294
Howard Todd United Kingdom 8 151 0.7× 98 0.6× 195 2.3× 13 0.2× 31 0.7× 9 439
H. Barr United Kingdom 10 204 1.0× 225 1.5× 27 0.3× 94 1.4× 34 0.8× 25 430
Ruth Dowling United Kingdom 8 164 0.8× 86 0.6× 72 0.8× 43 0.6× 14 0.3× 9 324
Simren K. Gill United Kingdom 8 121 0.6× 126 0.8× 76 0.9× 20 0.3× 28 0.6× 8 346
Amir Akhavan Rezayat Iran 8 138 0.6× 95 0.6× 44 0.5× 58 0.9× 22 0.5× 14 292
E. Amelina Russia 10 213 1.0× 93 0.6× 41 0.5× 14 0.2× 26 0.6× 77 321

Countries citing papers authored by R C Stern

Since Specialization
Citations

This map shows the geographic impact of R C Stern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R C Stern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R C Stern more than expected).

Fields of papers citing papers by R C Stern

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R C Stern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R C Stern. The network helps show where R C Stern may publish in the future.

Co-authorship network of co-authors of R C Stern

This figure shows the co-authorship network connecting the top 25 collaborators of R C Stern. A scholar is included among the top collaborators of R C Stern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R C Stern. R C Stern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Daniel, D.G., R C Stern, & Theresa R. Kramer. (1999). Switching from olanzapine to ziprasidone: An interim analysis of a 6-week study. European Neuropsychopharmacology. 9. 265–265. 7 indexed citations
2.
Sharma, Girish, Michael F. Tosi, R C Stern, & Pamela B. Davis. (1995). Progression of Pulmonary Disease After Disappearance of Pseudomonas in Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 152(1). 169–173. 13 indexed citations
3.
Stern, R C, et al.. (1994). Spontaneous bacterial peritonitis in cystic fibrosis.. Gut. 35(5). 709–711. 3 indexed citations
4.
Kirvelä, Olli, et al.. (1993). Long-term parenteral nutrition in cystic fibrosis.. PubMed. 9(2). 119–26. 14 indexed citations
5.
Aronoff, Stephen C. & R C Stern. (1988). Serum IgG Antibody to Outer Membrane Antigens of Pseudomonas cepacia and Pseudomonas aeruginosa in Cystic Fibrosis. The Journal of Infectious Diseases. 157(5). 934–940. 25 indexed citations
6.
Stern, R C. (1986). Cystic Fibrosis: Recent Developments in Diagnosis and Treatment. Pediatrics in Review. 7(9). 276–286. 7 indexed citations
7.
Stern, R C, et al.. (1982). OBSTRUCTIVE AZOOSPERMIA AS A DIAGNOSTIC CRITERION FOR THE CYSTIC FIBROSIS SYNDROME. The Lancet. 319(8286). 1401–1404. 44 indexed citations
8.
Thomassen, Mary Jane, et al.. (1979). Multiple Isolates of Pseudomonas aeruginosa with Differing Antimicrobial Susceptibility Patterns from Patients with Cystic Fibrosis. The Journal of Infectious Diseases. 140(6). 873–880. 119 indexed citations
10.
Stowe, Steven M., et al.. (1975). Open thoracotomy for pneumothorax in cystic fibrosis.. PubMed. 111(5). 611–7. 29 indexed citations
11.
12.
Stern, R C, et al.. (1966). Congestive pseudolobulation of the pancreas.. PubMed. 81(6). 558–62. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026